Imperative Care has received a green light from the FDA for its large-bore catheter to help remove stroke-causing blood clots ...

In this article, we are going to take a look at where Inari Medical ... a condition called venous thromboembolism, where a blood clot forms in a vein, and other vascular diseases.

based Stryker has offered $4.9 billion to buy Inari Medical Inc., a California company that specializes in equipment for venous thromboembolism (VTE) systems to treat blood clots such as pulmonary ...

The deal for Inari bolsters Stryker's efforts to build out its offerings to treat a condition called venous thromboembolism, where a blood clot forms in a vein, and other vascular diseases.

Inari’s catalog includes the catheter-based FlowTriever and ClotTriever systems for mechanically removing blood clots in cases of pulmonary embolism and deep vein thrombosis, respectively.

Inari Medical specializes in developing devices that treat patients with venous diseases, including venous thromboembolism, a condition where blood clots form in veins, posing serious health risks.

Canaccord downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $74, after Stryker (SYK) entered into a definitive agreement to acquire Inari in cash for $80 per share.

The deal for Inari bolsters Stryker’s efforts to build out its offerings to treat a condition called venous thromboembolism, where a blood clot forms in a vein, and other vascular diseases.

Stryker said on Monday that the medical-device maker will buy Inari Medical, which makes devices that treat patients with venous diseases, in a $4.9 billion deal. The deal for Inari, which has a ...

Even seeing one just existing brings a tear to the eye because they're too precious for words. This is everything Shadow the Golden Retriever puppy is and more—especially since he only just discovered ...